Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV . These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...
Information about TRUVADA and ATRIPLA delisting
Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...
UK report gives thumbs up to generic HIV drugs used as PrEP
A sexual health clinic in London has tested drug levels in users of generic PrEP medication bought online and found the drugs are genuine and effective.
Tests found adequate levels of both emtricitabine and tenofovir (used in PrEP medication Truvada) in patients’ blood, and no sample suggesting counterfeit drugs.
Read more here
See conference program here
London sexual health clinics step up their support for people buying PrEP online
nam/aidsmap, 29 January 2016 Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring to PrEP users. This is in a context of increasing frustration with the slowness of the official NHS process to approve PrEP – no decision will be made until June at the earliest. Read...